REMTOLUMAB
UNII 1V8WRH3RVX

Substance Identification & Data

This profile provides standardized clinical and technical data for Remtolumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1V8WRH3RVX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1791410-27-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1V8WRH3RVX

CAS Registry Number

1791410-27-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REMTOLUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152189

National Cancer Institute reference terminology for clinical and research data.

INN ID

10345

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Remtolumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

REMTOLUMAB

Common Names & Synonyms

REMTOLUMAB [INN]

REMTOLUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A) AND HOMO SAPIENS TNF (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 2, TNFSF2, TNF-ALPHA, TNFA)), HOMO SAPIENS MONOCLONAL ANTIBODY, TETRAVALENT BISPECIFIC GAMMA1 HEAVY CHAIN (1-587) (HOMO SAPIENS VH ANTI-TNF (IGHV3-9*01 (93.90%) -(IGHD) -IGHJ4*01) (8.8.14) (1- 121) -10-MER BIS(TETRAGLYCYL-SERYL) LINKER (122-132) -HOMO SAPIENS VH ANTI-IL17A (IGHV1-69*01 (85.70%) -(IGHD) - IGHJ6*01) (8.8.19) (132-257) -IGHG1*01, G1M17,1 (CH1 (258-355), HINGE (356-370), CH2 (371-480), CH3 (481- 585), CHS (586-587)) (258-587)), (360-331')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-331') (HOMO SAPIENS V-KAPPA ANTI- TNF (IGKV1-27*01 (95.80%) -IGKJ2*01) (6.3.9) (1'-107') - HOMO SAPIENS V-KAPPA ANTI-IL17A (IGKV6-21*01 (90.50%) -IGKJ3*01) (6.3.9) (118'-224') -IGKC*01, KM3 (225'-213'))DIMER (366-366'':369-369'')-BISDISULFIDE IMMUNOMODULATOR

SYS

IMMUNOGLOBULIN, ANTI-(TUMOR NECROSIS FACTOR .ALPHA./INTERLEUKIN 17) (SYNTHETIC HUMAN A-1230717 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN A-1230717 LIGHT CHAIN, DIMER

SYS